In the same rat model of glaucoma, pharmacological inhibition of NOS2 by aminoguanidine or L-N(6)-(1-iminoethyl)lysine 5-tetrazole amide reduced the number of RGCs that died [33,34]. The gene discussed is NOS2; the disease is glaucoma.